Project Description
![portfolio.logo.counsyl.exit](https://i0.wp.com/www.gramercyfund.com/wp-content/uploads/2019/03/portfolio.logo_.counsyl.exit_.jpg?resize=400%2C200&ssl=1)
DESCRIPTION:
Acquired by Myriad Genetics Inc.
Counsyl has developed the Universal Genetic Test: a simple, non-invasive, saliva-based test for more than 100 serious genetic diseases like cystic fibrosis, spinal muscular atrophy (SMA), sickle cell, and Tay-Sachs.
WEBSITE:
www.counsyl.com
CATEGORY:
Exits